Showing posts with label human. Show all posts
Showing posts with label human. Show all posts

Thursday, 3 July 2014

First show off, then take-off: New specimen of Archaeopteryx reveals previously unknown features of the plumage

Date:
July 3, 2014
Source:
Ludwig-Maximilians-Universitaet Muenchen (LMU)
Summary:
Paleontologists are currently studying a new specimen of Archaeopteryx, which reveals previously unknown features of the plumage. The initial findings shed light on the original function of feathers and their recruitment for flight.


Paleontologists of Ludwig-Maximilians-Universitaet (LMU) in Munich are currently studying a new specimen of Archaeopteryx, which reveals previously unknown features of the plumage. The initial findings shed light on the original function of feathers and their recruitment for flight.


A century and a half after its discovery and a mere 150 million years or so since it took to the air, Archaeopteryx still has surprises in store: The eleventh specimen of the iconic "basal bird" so far discovered turns out to have the best preserved plumage of all, permitting detailed comparisons to be made with other feathered dinosaurs. The fossil is being subjected to a thorough examination by a team led by Dr. Oliver Rauhut, a paleontologist in the Department of Earth and Environmental Sciences at LMU Munich, who is also affiliated with the Bavarian State Collection for Paleontology and Geology in Munich. The first results of their analysis of the plumage are reported in the latest issue of Nature. The new data make a significant contribution to the ongoing debate over the evolution of feathers and its relationship to avian flight. They also imply that the links between feather development and the origin of flight are probably much more complex than has been assumed up to now.
"For the first time, it has become possible to examine the detailed structure of the feathers on the body, the tail and, above all, on the legs," says Oliver Rauhut. In the case of this new specimen, the feathers are, for the most part, preserved as impressions in the rock matrix. "Comparisons with other feathered predatory dinosaurs indicate that the plumage in the different regions of the body varied widely between these species. That suggests that primordial feathers did not evolve in connection with flight-related roles, but originated in other functional contexts," says Dr. Christian Foth of LMU and the Bavarian State Collection for Paleontology and Geology in Munich, first author on the new paper.
To keep warm and to catch the eye
Predatory dinosaurs (theropods) with body plumage are now known to predate Archaeopteryx, and their feathers probably provided thermal insulation. Advanced species of predatory dinosaurs and primitive birds with feathered forelimbs may have used them as balance organs when running, like ostriches do today. Moreover, feathers could have served useful functions in brooding, camouflage and display. Indeed, the feathers on the tail, wings and hind-limbs most probably fulfilled functions in display, although it is very likely that Archaeopteryx was also capable of flight. "Interestingly, the lateral feathers in the tail of Archaeopteryx had an aerodynamic form, and most probably played an important role in its aerial abilities," says Foth.
On the basis of their investigation of the plumage of the new fossil, the researchers have been able to clarify the taxonomical relationship between Archaeopteryx and other species of feathered dinosaur. Here, the diversity in form and distribution of the feather tracts is particularly striking. For instance, among dinosaurs that had feathers on their legs, many had long feathers extending to the toes, while others had shorter down-like plumage. "If feathers had evolved originally for flight, functional constraints should have restricted their range of variation. And in primitive birds we do see less variation in wing feathers than in those on the hind-limbs or the tail," explains Foth.
These observations imply that feathers acquired their aerodynamic functions secondarily: Once feathers had been invented, they could be co-opted for flight. "It is even possible that the ability to fly evolved more than once within the theropods," says Rauhut. "Since the feathers were already present, different groups of predatory dinosaurs and their descendants, the birds, could have exploited these structures in different ways." The new results also contradict the theory that powered avian flight evolved from earlier four-winged species that were able to glide.
Archaeopteryx represents a transitional form between reptiles and birds and is the best-known, and possibly the earliest, bird fossil. It proves that modern birds are directly descended from predatory dinosaurs, and are themselves essentially modern-day dinosaurs. The many new fossil species of feathered dinosaurs discovered in China in recent years have made it possible to place Archaeopteryx within a larger evolutionary context. However, when feathers first appeared and how often flight evolved are matters that are still under debate.
The eleventh known specimen of Archaeopteryx is still in private hands. Like all other examples of the genus, it was found in the Altmühl valley in Bavaria, which in Late Jurassic times lay in the northern tropics, and at the bottom of a shallow sea, as all Archaeopteryx fossils found so far have been recovered from limestone deposits.

Story Source:
The above story is based on materials provided by Ludwig-Maximilians-Universitaet Muenchen (LMU)Note: Materials may be edited for content and length.

Journal Reference:
  1. Christian Foth, Helmut Tischlinger, Oliver W. M. Rauhut. New specimen of Archaeopteryx provides insights into the evolution of pennaceous feathers.Nature, 2014; 511 (7507): 79 DOI: 10.1038/nature13467

Tuesday, 1 July 2014

Muscle-powered bio-bots walk on command

Date:
July 1, 2014
Source:
University of Illinois at Urbana-Champaign
Summary:
A new generation of miniature biological robots is flexing its muscle. Engineers have demonstrated a class of walking 'bio-bots' powered by muscle cells and controlled with electrical pulses, giving researchers unprecedented command over their function.



A new generation of miniature biological robots is flexing its muscle. Engineers at the University of Illinois at Urbana-Champaign demonstrated a class of walking "bio-bots" powered by muscle cells and controlled with electrical pulses, giving researchers unprecedented command over their function. The group published its work in the online early edition of Proceedings of the National Academy of Sciences.

"Biological actuation driven by cells is a fundamental need for any kind of biological machine you want to build," said study leader Rashid Bashir, Abel Bliss Professor and head of bioengineering at the U. of I. "We're trying to integrate these principles of engineering with biology in a way that can be used to design and develop biological machines and systems for environmental and medical applications. Biology is tremendously powerful, and if we can somehow learn to harness its advantages for useful applications, it could bring about a lot of great things."
Bashir's group has been a pioneer in designing and building bio-bots, less than a centimeter in size, made of flexible 3-D printed hydrogels and living cells. Previously, the group demonstrated bio-bots that "walk" on their own, powered by beating heart cells from rats. However, heart cells constantly contract, denying researchers control over the bot's motion. This makes it difficult to use heart cells to engineer a bio-bot that can be turned on and off, sped up or slowed down.
The new bio-bots are powered by a strip of skeletal muscle cells that can be triggered by an electric pulse. This gives the researchers a simple way to control the bio-bots and opens the possibilities for other forward design principles, so engineers can customize bio-bots for specific applications.
"Skeletal muscles cells are very attractive because you can pace them using external signals," Bashir said. "For example, you would use skeletal muscle when designing a device that you wanted to start functioning when it senses a chemical or when it received a certain signal. To us, it's part of a design toolbox. We want to have different options that could be used by engineers to design these things."
The design is inspired by the muscle-tendon-bone complex found in nature. There is a backbone of 3-D printed hydrogel, strong enough to give the bio-bot structure but flexible enough to bend like a joint. Two posts serve to anchor a strip of muscle to the backbone, like tendons attach muscle to bone, but the posts also act as feet for the bio-bot.
A bot's speed can be controlled by adjusting the frequency of the electric pulses. A higher frequency causes the muscle to contract faster, thus speeding up the bio-bot's progress as seen in this video.
"It's only natural that we would start from a bio-mimetic design principle, such as the native organization of the musculoskeletal system, as a jumping-off point," said graduate student Caroline Cvetkovic, co-first author of the paper. "This work represents an important first step in the development and control of biological machines that can be stimulated, trained, or programmed to do work. It's exciting to think that this system could eventually evolve into a generation of biological machines that could aid in drug delivery, surgical robotics, 'smart' implants, or mobile environmental analyzers, among countless other applications."
Next, the researchers will work to gain even greater control over the bio-bots' motion, like integrating neurons so the bio-bots can be steered in different directions with light or chemical gradients. On the engineering side, they hope to design a hydrogel backbone that allows the bio-bot to move in different directions based on different signals. Thanks to 3-D printing, engineers can explore different shapes and designs quickly. Bashir and colleagues even plan to integrate a unit into undergraduate lab curriculum so that students can design different kinds of bio-bots.
"The goal of 'building with biology' is not a new one -- tissue engineering researchers have been working for many years to reverse engineer native tissue and organs, and this is very promising for medical applications," said graduate student Ritu Raman, co-first author of the paper. "But why stop there? We can go beyond this by using the dynamic abilities of cells to self-organize and respond to environmental cues to forward engineer non-natural biological machines and systems.
"The idea of doing forward engineering with these cell-based structures is very exciting," Bashir said. "Our goal is for these devices to be used as autonomous sensors. We want it to sense a specific chemical and move towards it, then release agents to neutralize the toxin, for example. Being in control of the actuation is a big step forward toward that goal."
The National Science Foundation supported this work through a Science and Technology Center (Emergent Behavior of Integrated Cellular Systems) grant, in collaboration with the Massachusetts Institute of Technology, the Georgia Institute of Technology and other partner institutions. Mechanical science and engineering professor Taher Saif was also a co-author. Bashir also is affiliated with the Micro and Nanotechnology Laboratory, the department of electrical and computer engineering and of mechanical science and engineering, Frederick Seitz Materials Research Laboratory and the Institute for Genomic Biology at the U. of I.

Story Source:
The above story is based on materials provided by University of Illinois at Urbana-ChampaignNote: Materials may be edited for content and length.

Journal Reference:
  1. C. Cvetkovic, R. Raman, V. Chan, B. J. Williams, M. Tolish, P. Bajaj, M. S. Sakar, H. H. Asada, M. T. A. Saif, R. Bashir. Three-dimensionally printed biological machines powered by skeletal muscleProceedings of the National Academy of Sciences, 2014; DOI: 10.1073/pnas.1401577111

Monday, 30 June 2014

Noninvasive brain control: New light-sensitive protein enables simpler, more powerful optogenetics

Date:
June 29, 2014
Source:
Massachusetts Institute of Technology
Summary:
Engineers have now developed the first light-sensitive molecule that enables neurons to be silenced noninvasively, using a light source outside the skull. This noninvasive approach could pave the way to using optogenetics in human patients to treat epilepsy and other neurological disorders.


Optogenetics, a technology that allows scientists to control brain activity by shining light on neurons, relies on light-sensitive proteins that can suppress or stimulate electrical signals within cells. This technique requires a light source to be implanted in the brain, where it can reach the cells to be controlled.

MIT engineers have now developed the first light-sensitive molecule that enables neurons to be silenced noninvasively, using a light source outside the skull. This makes it possible to do long-term studies without an implanted light source. The protein, known as Jaws, also allows a larger volume of tissue to be influenced at once.
This noninvasive approach could pave the way to using optogenetics in human patients to treat epilepsy and other neurological disorders, the researchers say, although much more testing and development is needed. Led by Ed Boyden, an associate professor of biological engineering and brain and cognitive sciences at MIT, the researchers described the protein in the June 29 issue of Nature Neuroscience.
Optogenetics, a technique developed over the past 15 years, has become a common laboratory tool for shutting off or stimulating specific types of neurons in the brain, allowing neuroscientists to learn much more about their functions.
The neurons to be studied must be genetically engineered to produce light-sensitive proteins known as opsins, which are channels or pumps that influence electrical activity by controlling the flow of ions in or out of cells. Researchers then insert a light source, such as an optical fiber, into the brain to control the selected neurons.
Such implants can be difficult to insert, however, and can be incompatible with many kinds of experiments, such as studies of development, during which the brain changes size, or of neurodegenerative disorders, during which the implant can interact with brain physiology. In addition, it is difficult to perform long-term studies of chronic diseases with these implants.
Mining nature's diversity
To find a better alternative, Boyden, graduate student Amy Chuong, and colleagues turned to the natural world. Many microbes and other organisms use opsins to detect light and react to their environment. Most of the natural opsins now used for optogenetics respond best to blue or green light.
Boyden's team had previously identified two light-sensitive chloride ion pumps that respond to red light, which can penetrate deeper into living tissue. However, these molecules, found in the bacteria Haloarcula marismortui and Haloarcula vallismortis, did not induce a strong enough photocurrent -- an electric current in response to light -- to be useful in controlling neuron activity.
Chuong set out to improve the photocurrent by looking for relatives of these proteins and testing their electrical activity. She then engineered one of these relatives by making many different mutants. The result of this screen, Jaws, retained its red-light sensitivity but had a much stronger photocurrent -- enough to shut down neural activity.
"This exemplifies how the genomic diversity of the natural world can yield powerful reagents that can be of use in biology and neuroscience," says Boyden, who is a member of MIT's Media Lab and the McGovern Institute for Brain Research.
Using this opsin, the researchers were able to shut down neuronal activity in the mouse brain with a light source outside the animal's head. The suppression occurred as deep as 3 millimeters in the brain, and was just as effective as that of existing silencers that rely on other colors of light delivered via conventional invasive illumination.
A key advantage to this opsin is that it could enable optogenetic studies of animals with larger brains, says Garret Stuber, an assistant professor of psychiatry and cell biology and physiology at the University of North Carolina at Chapel Hill.
"In animals with larger brains, people have had difficulty getting behavior effects with optogenetics, and one possible reason is that not enough of the tissue is being inhibited," he says. "This could potentially alleviate that."
Restoring vision
Working with researchers at the Friedrich Miescher Institute for Biomedical Research in Switzerland, the MIT team also tested Jaws's ability to restore the light sensitivity of retinal cells called cones. In people with a disease called retinitis pigmentosa, cones slowly atrophy, eventually causing blindness.
Friedrich Miescher Institute scientists Botond Roska and Volker Busskamp have previously shown that some vision can be restored in mice by engineering those cone cells to express light-sensitive proteins. In the new paper, Roska and Busskamp tested the Jaws protein in the mouse retina and found that it more closely resembled the eye's natural opsins and offered a greater range of light sensitivity, making it potentially more useful for treating retinitis pigmentosa.
This type of noninvasive approach to optogenetics could also represent a step toward developing optogenetic treatments for diseases such as epilepsy, which could be controlled by shutting off misfiring neurons that cause seizures, Boyden says. "Since these molecules come from species other than humans, many studies must be done to evaluate their safety and efficacy in the context of treatment," he says.
Boyden's lab is working with many other research groups to further test the Jaws opsin for other applications. The team is also seeking new light-sensitive proteins and is working on high-throughput screening approaches that could speed up the development of such proteins.
The research at MIT was funded by Jerry and Marge Burnett, the Defense Advanced Research Projects Agency, the Human Frontiers Science Program, the IET A. F. Harvey Prize, the Janet and Sheldon Razin '59 Fellowship of the MIT McGovern Institute, the New York Stem Cell Foundation-Robertson Investigator Award, the National Institutes of Health, the National Science Foundation, and the Wallace H. Coulter Foundation.

Story Source:
The above story is based on materials provided by Massachusetts Institute of Technology. The original article was written by Anne Trafton. Note: Materials may be edited for content and length.

In human evolution, changes in skin's barrier set northern Europeans apart

Date:
June 30, 2014
Source:
University of California, San Francisco (UCSF)
Summary:
The popular idea that northern Europeans developed light skin to absorb more UV light so they could make more vitamin D -- vital for healthy bones and immune function -- is questioned by researchers in a new study. Ramping up the skin’s capacity to capture UV light to make vitamin D is indeed important, however, researchers concluded in their study that changes in the skin’s function as a barrier to the elements made a greater contribution than alterations in skin pigment in the ability of northern Europeans to make vitamin D.


The popular idea that Northern Europeans developed light skin to absorb more UV light so they could make more vitamin D – vital for healthy bones and immune function – is questioned by UC San Francisco researchers in a new study published online in the journal Evolutionary Biology



Ramping up the skin’s capacity to capture UV light to make vitamin D is indeed important, according to a team led by Peter Elias, MD, a UCSF professor of dermatology. However, Elias and colleagues concluded in their study that changes in the skin’s function as a barrier to the elements made a greater contribution than alterations in skin pigment in the ability of Northern Europeans to make vitamin D.
Elias’ team concluded that genetic mutations compromising the skin’s ability to serve as a barrier allowed fair-skinned Northern Europeans to populate latitudes where too little ultraviolet B (UVB) light for vitamin D production penetrates the atmosphere.
Among scientists studying human evolution, it has been almost universally assumed that the need to make more vitamin D at Northern latitudes drove genetic mutations that reduce production of the pigment melanin, the main determinant of skin tone, according to Elias.
“At the higher latitudes of Great Britain, Scandinavia and the Baltic States, as well as Northern Germany and France, very little UVB light reaches the Earth, and it’s the key wavelength required by the skin for vitamin D generation,” Elias said.
“While is seems logical that the loss of the pigment melanin would serve as a compensatory mechanism, allowing for more irradiation of the skin surface and therefore more vitamin D production, this hypothesis is flawed for many reasons,” he continued. “For example, recent studies show that dark-skinned humans make vitamin D after sun exposure as efficiently as lightly-pigmented humans, and osteoporosis – which can be a sign of vitamin D deficiency – is less common, rather than more common, in darkly-pigmented humans.”
Furthermore, evidence for a south to north gradient in the prevalence of melanin mutations is weaker than for this alternative explanation explored by Elias and colleagues.
In earlier research, Elias began studying the role of skin as a barrier to water loss. He recently has focused on a specific skin-barrier protein called filaggrin, which is broken down into a molecule called urocanic acid – the most potent absorber of UVB light in the skin, according to Elias. “It’s certainly more important than melanin in lightly-pigmented skin,” he said.
In their new study, the researchers identified a strikingly higher prevalence of inborn mutations in the filaggrin gene among Northern European populations. Up to 10 percent of normal individuals carried mutations in the filaggrin gene in these northern nations, in contrast to much lower mutation rates in southern European, Asian and African populations.
Moreover, higher filaggrin mutation rates, which result in a loss of urocanic acid, correlated with higher vitamin D levels in the blood. Latitude-dependent variations in melanin genes are not similarly associated with vitamin D levels, according to Elias. This evidence suggests that changes in the skin barrier played a role in Northern European’s evolutionary adaptation to Northern latitudes, the study concluded.
Yet, there was an evolutionary tradeoff for these barrier-weakening filaggrin mutations, Elias said. Mutation bearers have a tendency for very dry skin, and are vulnerable to atopic dermatitis, asthma and food allergies. But these diseases have appeared only recently, and did not become a problem until humans began to live in densely populated urban environments, Elias said.
The Elias lab has shown that pigmented skin provides a better skin barrier, which he says was critically important for protection against dehydration and infections among ancestral humans living in sub-Saharan Africa. But the need for pigment to provide this extra protection waned as modern human populations migrated northward over the past 60,000 years or so, Elias said, while the need to absorb UVB light became greater, particularly for those humans who migrated to the far North behind retreating glaciers less than 10,000 years ago.
The data from the new study do not explain why Northern Europeans lost melanin. If the need to make more vitamin D did not drive pigment loss, what did? Elias speculates that, “Once human populations migrated northward, away from the tropical onslaught of UVB, pigment was gradually lost in service of metabolic conservation. The body will not waste precious energy and proteins to make proteins that it no longer needs.”
For the Evolutionary Biology study, labeled a “synthesis paper” by the journal, Elias and co-author Jacob P. Thyssen, MD, a professor at the University of Copenhagen, mapped the mutation data and measured the correlations with blood levels of vitamin D. Labs throughout the world identified the mutations. Daniel Bikle, MD, PhD, a UCSF professor of medicine, provided expertise on vitamin D metabolism.

Story Source:
The above story is based on materials provided by University of California, San Francisco (UCSF). The original article was written by Jeffrey Norris. Note: Materials may be edited for content and length.

Journal Reference:
  1. Jacob P. Thyssen, Daniel D. Bikle, Peter M. Elias. Evidence That Loss-of-Function Filaggrin Gene Mutations Evolved in Northern Europeans to Favor Intracutaneous Vitamin D3 ProductionEvolutionary Biology, 2014; DOI:10.1007/s11692-014-9282-7